Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Amine Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Patent CN102951980A reveals a novel iridium-catalyzed method for producing chiral amines, offering significant cost reduction in agrochemical intermediate manufacturing and scalable supply chain solutions.
Patent CN110551032B details a high-efficiency iridium-catalyzed asymmetric reductive amination method, offering significant cost reduction in agrochemical manufacturing and reliable supply chain solutions.
Patent CN110914417B reveals high-activity transaminase for chiral amine synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel ferrocene-derived iridium catalyst enables high-efficiency chiral amine synthesis with reduced processing costs for reliable agrochemical intermediate supply chains.
Patent CN1328230C details asymmetric transfer hydrogenation of imines using Rh/Ru/Ir catalysts for high-purity pharmaceutical intermediates.
Patent CN105112468A reveals multi-enzyme systems for chiral amine synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable biocatalysis.
Novel enzymatic synthesis method for high-purity chiral cis-cyclohexanediamine. Scalable process reduces impurities and ensures supply chain reliability for anticoagulant manufacturing.
Patent CN110862324A discloses a novel iridium-catalyzed asymmetric reductive amination method achieving up to 95% ee for key pharmaceutical intermediates like Cinacalcet.
Patent CN110551033B details a novel Ir-catalyzed asymmetric reductive amination method. Achieve high enantioselectivity and cost reduction in chiral amine manufacturing with scalable processes.
Patent CN110551033B details a high-efficiency iridium-catalyzed asymmetric reductive amination method. Achieve superior enantioselectivity and cost reduction in chiral amine manufacturing for pharma and agrochemicals.
Patent CN110551032A details iridium catalyzed asymmetric reductive amination. Delivers high purity chiral amines with significant supply chain and cost advantages.
Patent CN110194735B details a visible light catalytic method for chiral amines. Offers high ee values and metal-free conditions for efficient API intermediate manufacturing.
Patent CN110551036A reveals a high-efficiency iridium catalytic system for chiral amine synthesis, offering significant cost reduction and supply chain reliability for agrochemical intermediates.
Patent CN111285775B reveals a high-efficiency iridium catalytic system for chiral amine synthesis, offering significant cost reduction and scalability for agrochemical intermediates.
Patent CN110551035A details high-efficiency iridium catalysis for chiral amines. Offers significant cost reduction and supply chain reliability for agrochemical intermediate manufacturing.
Patent CN110551036B details a high-efficiency iridium-catalyzed asymmetric hydrogenation method for chiral amines, offering superior enantioselectivity and industrial scalability for agrochemical intermediates.
Patent CN110551037B details a high-efficiency iridium/chiral diphosphine system for asymmetric hydrogenation, offering superior enantioselectivity for agrochemical intermediates.
Novel iridium catalyst system enables high-yield asymmetric hydrogenation for metolachlor intermediates, offering scalable cost reduction and supply reliability.
Patent CN114539328B reveals surfactant-promoted route enhancing yield and purity. Delivers supply chain stability and cost efficiency for global buyers.